HS-20094
Efficacy and Safety of Olatorepatide Versus Placebo in Adults With Moderate to Severe Hidradenitis Suppurativa Living With Overweight or Obesity
Regeneron · Phase 2 · Not yet recruiting · Enrollment 300
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| Olatorepatide | Hidradenitis Suppurativa | n/r | n/r | n/r | n/r |
| Placebo | Hidradenitis Suppurativa | n/r | n/r | n/r | n/r |